# Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

> **NCT01576952** · PHASE3 · COMPLETED · sponsor: **Sun Pharmaceutical Industries Limited** · enrollment: 268 (actual)

## Conditions studied

- Ocular Inflammation

## Interventions

- **DRUG:** ISV-303
- **OTHER:** DuraSite Vehicle

## Key facts

- **NCT ID:** NCT01576952
- **Lead sponsor:** Sun Pharmaceutical Industries Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 268 (ACTUAL)
- **Last updated:** 2021-11-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01576952

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01576952, "Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01576952. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*